Drug: tyvaso Quarter: 2016Q3
Total Records: 586 Number of Pages: 30
| DRUGNAME | PT | EventCount |
|---|---|---|
| TYVASO | Infusion site haemorrhage | 2 |
| TYVASO | Infusion site warmth | 2 |
| TYVASO | Injection site pain | 2 |
| TYVASO | Injection site pruritus | 2 |
| TYVASO | Intervertebral disc protrusion | 2 |
| TYVASO | Irritable bowel syndrome | 2 |
| TYVASO | Joint dislocation | 2 |
| TYVASO | Joint range of motion decreased | 2 |
| TYVASO | Kidney infection | 2 |
| TYVASO | Large intestine perforation | 2 |
| TYVASO | Lethargy | 2 |
| TYVASO | Limb injury | 2 |
| TYVASO | Meningitis | 2 |
| TYVASO | Mobility decreased | 2 |
| TYVASO | Mouth ulceration | 2 |
| TYVASO | Musculoskeletal chest pain | 2 |
| TYVASO | Myocardial necrosis marker increased | 2 |
| TYVASO | N-terminal prohormone brain natriuretic peptide increased | 2 |
| TYVASO | Nasal discomfort | 2 |
| TYVASO | Nasal dryness | 2 |
Total Records: 586 Number of Pages: 30